Carregant...
Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans
Multiple preventive vaccines are being developed to counter the coronavirus disease 2019 pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) and human phase 1 and/or phase 2 clinical trials. Several vaccines have already advanced into phase 3 efficacy trials, while o...
Guardat en:
| Publicat a: | Sci Adv |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Association for the Advancement of Science
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7978427/ https://ncbi.nlm.nih.gov/pubmed/33608249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abe8065 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|